Sun Pharmaceutical Shows Mixed Trends Amidst Sector Performance and Market Dynamics
Sun Pharmaceutical Industries is currently trading at Rs 1696.5, with a market capitalization of Rs 4,10,694.17 crore. The stock has shown mixed trends relative to its moving averages and has experienced a year-to-date decline of 9.17%, despite strong long-term performance, outperforming the Sensex over three and five years.
Sun Pharmaceutical Industries has shown notable activity today, trading at Rs 1696.5, which aligns with the sector's performance. The stock's current price is above its 5-day, 20-day, and 50-day moving averages, yet it remains below the 100-day and 200-day moving averages, indicating mixed short- to medium-term trends.With a market capitalization of Rs 4,10,694.17 crore, Sun Pharma operates within the Pharmaceuticals & Biotechnology industry, boasting a price-to-earnings (P/E) ratio of 35.57, slightly below the industry average of 36.55.
In terms of performance metrics, Sun Pharmaceutical Industries has experienced a year-to-date decline of 9.17%, contrasting with the Sensex's gain of 3.50%. However, the stock has shown resilience over shorter time frames, with a 1-day increase of 0.99% and a 1-week rise of 1.95%, while the Sensex has faced declines in those periods.
Over the past three years, the stock has delivered an impressive return of 81.41%, significantly outperforming the Sensex's 40.48% during the same timeframe. In the last five years, it has surged by 247.20%, compared to the Sensex's 112.43%.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Most Read
